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Abstract		
Transient	loss	of	consciousness	(LOC)	is	very	common	issue.	Syncopes	and	generalized	tonic-
clonic	(GTC)	seizures	are	common	causes	mostly	differentiated	by	history.	Several	laboratories	
serum	markers	(mostly	creatine	kinase	and	lactate)	can	be	helpful	especially	when	history	is	
unreliable.	 We	 explore	 the	 potential	 supporting	 role	 of	 electrolytes	 plasma	 level	 in	 that	
setting.	
We	retrospectively	collected	178	consecutive	episodes	of	loss	of	consciousness	in	adults	from	
the	 EEG	 database	 of	 our	 hospital	 (CHUV,	 Lausanne)	 seen	 over	 3	 years	 in	 our	 emergency	
department.	 Plasma	 level	 of	 the	 different	 electrolytes	 (sodium,	 potassium,	 phosphate,	
calcium,	magnesium)	were	recorded	as	well	as	basic	demographics,	diagnosis,	blood	sample	
delay	and	history	of	alcohol	abuse.		
We	analysed	128	episodes	with	 sufficient	documentations	 (7	had	uncertain	diagnosis):	we	
compared	 electrolytes	 values	 between	 GTC	 seizures	 (75	 episodes)	 and	 other	 LOC,	 (46	
episodes).	 Phosphate	 and	 calcium	 levels	were	 associated	with	 GTC	 seizures;	median=0.79	
(range	0.34-1.37)	vs	0.93	mmol/l	(range	0.52-1.56)	p=0.001	for	phosphate	and	median=	2.32	
(range	1.92-2.53)	vs	2.27	mmol/l	(range	2.0-2.53)	p=0.03	for	calcium.	Considering	abnormal	
values,	only	hypophosphatemia	(94%	of	abnormal	phosphate	level)	was	associated	with	GTC	
seizures	 with	 37	 (51	 %)	 abnormal	 phosphate	 in	 GTC	 seizures	 and	 15	 (33%)	 in	 other	 LOC	
(p=0.02,	 Chi	 squared),	 independently	 from	blood	 sampling	delay,	 alcohol	 abuse	 and	other	
electrolytes	level.	Hypophosphatemia	below	0.6	mmol/L	was	93%	sensitive	and	85%	specific	
of	GTC	seizure.	Hypophosphatemia	was	self-limited.	
Our	 data	 suggest	 that	 transient	 hypophosphatemia	 is	 common	 after	 GTC	 seizures.	 This	
hypophosphatemia	 is	 unlikely	 to	 be	 causing	 the	 seizure,	 but	 is	 rather	 a	 consequent	
intracellular	shift.	Phosphate	 level	could	be	another	biological	marker	helping	differentiate	
GTC	seizures	from	other	LOC,	especially	when	history	is	unclear.	Timing	of	the	blood	sample	
	 	 	
	
should	be	taking	into	account	in	its	interpretation.	A	prospective	study	is	needed	to	confirm	
these	findings.	
	 	 	
	
Introduction	
Loss	 of	 consciousness	 (LOC)	 is	 a	 common	 cause	 of	 admission	 in	 emergency	 departments	
accounting	for	1	in	20	admissions1.	Assessing	the	nature	of	the	episodes	mostly	rely	on	history	
taking	and	clinical	examination2,	half	of	these	episodes	are	diagnosed	as	generalised	tonic-
clonic	 (GTC)	 seizures3.	 There	 are	 currently	 no	 gold	 standard	 paraclinical	 examination	
distinguishing	syncopes	from	convulsive	seizures.	A	blood	sample	 is	routinely	performed	in	
case	of	suspicion	of	an	epileptic	seizure	as	part	of	the	etiological	work-up4.	GTC	seizures	induce	
plasma	 changes	 can	 be	 used	 to	 help	 assessing	 transient	 LOC,	 when	 history	 and	 clinical	
examination	are	unyielding.	
Seizures	 are	 long	 known	 to	 induce	 systemic	 changes	 such	 as	 plasma	 prolactin5-8,	 creatine	
kinase	 (CK)	 (typically	 with	 a	 few	 hours	 delay)6,	 9-11,	 lactate	 12,	 13,	 ammonium14,	 15	
adrenocorticotropic	 hormone	 (ACTH)	 16	 and	 cortisol	 increases8,	 16.	 Other	 studies	 also	
suggested	serum	growth	hormone	 (GH)	 levels	 increase17,	but	not	consistently16.	Several	of	
these	studies	also	assessed	prolactin	6,	17,	18	,	lactate19	or	CK	6,	10	increase	as	markers	mostly	to	
differentiate	 GTC	 seizure	 versus	 non	 epileptic	 psychogenic	 seizures	 or	 syncopes.	 Some	 of	
these	markers	(such	as	prolactin)	allow	mostly	the	differentiation	between	GTC	seizures	and	
syncopes	versus	psychogenic	non	epileptic	attacks20.	Recently	seizure	were	also	found	to	be	
associated	with	an	 increase	of	multiple	 inflammatory	parameters12.	Except	 lactate,	CK	and	
ammonium,	 other	 markers	 are	 seldom	 used	 in	 clinical	 practice	 to	 assist	 the	 diagnosis	 of	
transient	LOC	as	these	tests	are	uncommonly	available	in	emergency	settings.	
	In	our	centre,	when	an	epileptic	seizure	is	part	of	the	differential	diagnosis,	a	full	electrolytic	
work-up	 (including	 calcium,	 magnesium,	 phosphate)	 is	 performed.	 We	 observed	 that	
abnormal	phosphate	 level	was	not	uncommonly	found	 in	patients	assessed	 in	that	setting.	
The	aim	of	this	study	was	to	assess	the	value	of	plasma	electrolytes	levels	in	the	assessment	
of	transient	LOC	whether	this	could	represent	another	help	for	diagnose	GTC	seizures	from	
others	causes	of	transient	LOC.		
	
	
	 	 	
	
Methods	
This	study	was	approved	by	our	local	ethic	committee,	and	the	need	to	consent	was	waived	
given	the	fully	retrospective	nature	of	the	study.	
We	identified	all	consecutive	episodes	of	transient	LOC	from	the	EEG	reports	database	of	our	
hospital	 (CHUV,	 Lausanne)	 using	 the	 following	 keywords:	 “syncope”,	 “fainting”,	
“consciousness”,	 “loss”,	 “seizure”,	 “convulsions”,	 “tonic-clonic”	 in	 the	 period	 between	
01.01.2014	and	31.12.2016.	We	included	only	adult	patients	(at	least	age	18	on	the	day	of	the	
hospital	admission).	For	each	episode,	we	recorded	the	following	data	from	electronic	medical	
notes:	gender;	age;	diagnosis	at	discharge	(based	on	discharge	summary);	as	well	as	history	
alcohol/toxic	abuse.	Laboratory	value	(in	mmol/l)	for	plasma	sodium,	potassium,	phosphate,	
total	 calcium	 and	 magnesium	 level	 were	 recorded;	 delay	 between	 the	 event	 and	 blood	
samples	were	also	recorded.	When	follow-up	was	available	for	these	laboratory	values,	it	was	
also	recorded.	
Statistical	analyses	were	performed	using	SPSS	version	25	(IBM	inc.).	Chi	square,	Fisher’s	exact	
test,	Mann-Whitney	tests	were	used	as	needed	for	univariable	analyses.	Receiver	operating	
characteristic	 (ROC)	 was	 used	 to	 assess	 sensitivity	 and	 specificity	 for	 a	 change.	 Backward	
multiple	regression	were	used	to	correct	for	potential	confounders	(such	delay	between	event	
and	blood	test,	alcohol	abuse)	and	assess	the	predictor	value	of	all	electrolytes	considered	
together.		
Results	
We	 identified	187	episodes,	we	excluded	59	cases	whose	documentation	was	 incomplete.	
Among	 the	 128	 episodes	 left,	 there	 was	 126	 patients	 (2	 people	 had	 2	 episodes).	 All	
demographic	data	can	be	found	in	table	1.	The	diagnoses	at	discharges	can	be	summarised	as	
follows:	75	episodes	were	diagnosed	tonic-clonic	seizures	(58.6%),	25	were	syncopes	(19.5%),	
11	were	focal	seizures	with	loss	of	awareness	(8.6%),	10	were	other	diagnoses	(psychogenic	
non-epileptic	 attack,	 acute	 confusional	 state,	 concussion,	 hyperventilation	 episode)	 (7.9%)	
and	7	unclear	episodes	for	which	the	possibility	of	general	tonic-clonic	seizure	could	not	be	
determined	(5.5%).	
	 	 	
	
We	 then	 differentiated	 between	 GTC	 seizures	 and	 other	 LOC	 (the	 seven	 episodes	 with	
uncertain	diagnosis	were	not	included	in	these	analyses).	There	was	no	significant	difference	
in	demographic	 terms	between	GTC	seizures	and	other	LOC	(details	are	shown	 in	table	1).	
There	was	a	significantly	shorter	delay	in	blood	samples	for	the	GTC	seizures	in	comparison	to	
other	LOC	episodes	(median	1.7h	vs	2h,	p=0.003,	Mann-Whitney)	and	greater	prevalence	of	
alcohol	abuse	in	GTC	seizures	(10%	vs	0%,	p=0.03,	Fisher’s	exact).	Electrolytes	changes	in	GTC	
seizures	 and	 other	 losses	 of	 consciousness	 episodes	 are	 shown	 in	 figure	 1.	 Considering	
electrolytes	 level	 values,	 phosphate	 and	 calcium	were	 independently	 associated	with	GTC	
seizures;	 median=0.79	 (range	 0.34-1.37)	 vs	 0.93mmol(l	 (range	 0.52-1.56)	 p=0.001	 for	
phosphate	 and	median=	 2.32	 (range	 1.92-2.53)	 vs	 2.27mmol/l	 (range	 2.0-2.53)	 p=0.03	 for	
calcium.	Considering	abnormal	values,	only	phosphate	values	were	associated	with	seizures,	
with	37	 (51	%)	abnormal	values	 in	GTC	seizures	 in	comparison	with	15	 (33%)	 in	other	LOC	
episodes	 (p=0.02,	 Chi	 squared).	 The	 vast	 majority	 of	 abnormal	 phosphate	 levels	 was	 a	
decreased	 below	 0.8	 mmol/L	 (47	 of	 50,	 94%)	 while	 only	 3	 (6	 %)	 were	 increased	 above	
1.4mmol/l.	 None	 of	 the	 seizures	 or	 other	 LOCs	 was	 considered	 as	 being	 caused	 by	
hypophosphatemia.	We	searched	in	the	10	most	severely	low	phosphatemia	for	the	use	of	
diuretic	medication,	but	we	did	not	find	any.	
Hypophosphatemia	was	the	only	variable	independently	associated	with	the	diagnostic	of	GTC	
seizure	when	correcting	for	delay	in	blood	sample,	other	electrolytes,	alcohol	abuse,	age,	and	
gender.	 The	presence	of	 abnormal	hypophosphatemia	 increased	 the	 chance	of	diagnosing	
GTC	seizure	by	2.5	fold	(95%	CI:	1.5-5.6,	p=0.02),	when	correcting	for	abnormal	calcium	(as	
there	was	a	trend	toward	higher	calcemia	in	GTC	seizures),	this	effect	increased	(OR:	3.2,	95%	
CI:	1.34-7.6,	p=0.008).	Using	ROC,	phosphate	level	below	0.6	mmol/L	was	associated	with	93%	
sensitivity	 and	 85%	 specificity	 for	 diagnosis	 of	 GTC	 seizure.	 Finally	 when	 comparing	 GTC	
seizures	and	focal	seizures,	somewhat	higher	proportion	of	hypophosphatemia	was	found	in	
GTC	(37,	51%)	than	in	focal	seizures	(4,	40%),	but	this	did	not	reach	significance.	
There	was	 significant	 correlation	 (p=0.01,	 two	 tailed	Pearson)	between	 the	delay	of	blood	
sampling	 and	phosphate	 level,	which	 tend	 to	 normalise	with	 the	 sample	 delay	 increasing.	
Phosphate	levels	were	higher	after	the	median	delay	of	blood	sampling	(2hours)	compared	to	
	 	 	
	
earlier,	 (median	 phosphatemia	 level	 was	 0.8mmol/L;	 range:	 0.35-1.34	 before	 the	 median	
sampling	delay	versus	0.95;	range:	0.34-1.35	after	the	median	sampling	time).		In	three	cases,	
patients	with	initial	hypophosphatemia	had	several	sequential	follow-up	levels	as	follow-up;	
2	of	them	normalized	(0.66	to	1.16	in	2h	10minutes	and	0.64	to	1.3mmol/l	in	1	hour),	while	
the	third	one	showed	no	normalisation	(0.5	to	0.47mmol	in	7	hours)	in	a	context	of	alcohol	
abuse.		
Discussion	
Electrolytes	abnormalities	are	common	in	patients	investigated	for	transient	LOC;	laboratory	
showed	abnormalities	in	more	than	half	of	the	episodes.	Phosphate	abnormalities	were	the	
most	 common	 and	 showed	 a	 differential	 distribution	 according	 the	 established	 diagnosis.	
Namely,	hypophosphatemia	was	seen	in	every	second	GTC	seizure	and	less	commonly	in	other	
LOC	 episodes.	 This	 significant	 association	 was	 not	 explained	 by	 confounders	 such	 as	
differential	delay	 in	blood	sampling	(GTC	seizure	had	understandably	short	delays),	alcohol	
abuse	 (with	 its	 risk	 of	 poor	 nutrition)	 or	 use	 of	 diuretics	 (which	 can	 lead	 to	 renal	 loss	 of	
phosphate).	
Hypophosphatemia	 can	 conceivably	 be	 considered	 as	 the	 cause	 of	 the	 diagnosed	 seizure.	
Disturbance	of	phosphate	plasma	level	are	however	not	recognized	as	a	cause	of	provoked	
seizures21,	cases	of	seizure	associated	with	hypophosphatemia	were	indeed	rarely	reported,	
and	 generally	 associated	 with	 other	 disturbances	 (refeeding	 syndrome	 and	 mechanical	
hyperventilation	in	intensive	care	unit)	22-24.	In	the	series	reported	here,	hypophosphatemia	
was	not	considered	as	the	cause	of	the	episodes.	The	time	course	of	phosphate	levels	as	well	
as	the	few	follow-up	data	also	suggest	a	transitory	self-limited	phenomenon.		
Our	data	suggest	 that	hypophosphatemia	 is	 rather	a	consequence	of	GTC	seizures	 than	 its	
cause.	 The	 tendency	 of	 hypophosphatemia	 to	 normalise	 over	 a	 few	 hours	 spontaneously	
suggests	a	redistribution	mechanisms	rather	than	a	loss	through	renal	excretion	for	instance.	
There	 are	 several	 explanations	 to	 this	 phenomenon	 that	 could	 be	 the	 consequences	 of	 a	
physiological	stress.	Indeed,	it	is	known	that	stress	hormones	such	as	epinephrine	or	glucagon	
can	 lead	 to	 electrolytes	 redistribution,	 and	 especially	 considerable	 intracellular	 phosphate	
	 	 	
	
shifts25,	26.	Intense	efforts	have	also	been	found	to	cause	PTH	variation	which	leads	to	transient	
hypophosphatemia27.	Hypophosphatemia	in	a	setting	of	transient	LOC	could	therefore	hint	a	
peak	of	stress	hormones	and	sustained	muscular	activity	during	the	course	of	the	episode.	
Plasma	 hypophosphatemia	 following	 an	 episode	 of	 LOC	 could	 therefore	 represent	 a	
biomarker	and	consequently	a	diagnostic	help	to	clarify	the	nature	of	such	episode.	 In	our	
study,	 presence	of	 hypophosphatemia	was	 associated	with	 a	 2.5	 fold	 increased	 chance	of	
diagnosing	a	convulsive	seizure.	Phosphate	concentration	in	blood	samples	collected	after	a	
LOC	 could	 be	 useful	 in	 clinical	 practice	 to	 assess	 the	 likelihood	 of	 a	 GTC	 seizure	 episode,	
especially	in	absence	of	history,	especially	when	phosphatemia	is	below	0.6	mmol/l.	In	terms	
of	sensitivity	and	specificity,	the	value	of	hypophosphatemia	seems	roughly	similar	to	other	
established	markers28.	 For	CK,	 an	elevation	of	>	15	U/l	 is	helpful	distinguishing	GTCs	 from	
syncope	with	a	sensitivity	of	69%	and	a	specificity	of	94%	29,	while	a	threshold	of	2.3	mmol/l	
for	lactate	level	is	associated	with	73%	sensitivity	and	97%	specificity	30	for	GTC	seizures	vs	
other	LOCs.	A	cut-off	of	65	µg/dl	for	ammonium	at	arrival	at	the	emergency	room	could	help	
differentiating	GTCs	from	other	cause	of	LOC	with	a	poorer	sensitivity	(53%)	but	a	specificity	
of	90%31.	Hypophosphatemia	(especially	in	absence	of	abnormal	calcium	level)	could	provide	
an	additional	clue	in	the	assessment	of	transient	LOC	to	differentiate	between	GTC	seizures	
and	other	LOC	such	as	syncope.	The	delay	between	the	event	and	the	blood	sample	must	also	
be	taken	into	account	as	our	results	suggest	this	is	self-limited	phenomenon	that	is	likely	to	
subside	spontaneous	in	most	case	over	the	hours	following	the	LOC.	
Our	study	has	limitations.	The	retrospective	design	has	several	consequences.	It	may	lead	to	
a	selection	bias	as	we	selected	patients	from	a	neurological	point	of	view	(all	episodes	were	
identified	 by	 their	 EEG	 recording)	 and	 as	 such	 there	was	 at	 least	 an	 initial	 doubt	 about	 a	
potential	 epileptic	 seizures	 in	 these	 episodes.	 We	 had	 therefore	 probably	 less	 clear-cut	
syncope	 that	 would	 have	 not	 needed	 neurological	 investigation.	 One	 advantage	 of	 such	
approach	 is	 that	 all	 episodes	 were	 comprehensively	 assessed	 by	 consulting	 neurologists,	
making	the	diagnosis	of	GTC	seizure	as	reliable	as	possible.	The	syncopes	explored	here	are	
also	 those	 leading	 to	diagnosis	difficulties	possibly	associated	with	myoclonic	 jerks.	 	 There	
could	be	also	be	an	information	bias	as	the	treating	physician	was	aware	about	the	abnormal	
	 	 	
	
phosphate	 level	 before	 establishing	 the	 diagnosis.	 We	 cannot	 therefore	 exclude	 that	
abnormal	electrolytes	may	have	 influenced	the	treating	physician	 in	case	of	uncertainty	to	
consider	 a	 diagnosis	 of	 epileptic	 seizure	 rather	 than	 a	 syncope.	 In	 no	 cases,	was	 however	
abnormal	 phosphate	 level	 reported	 as	 a	 triggering	 factor	or	 a	 cause	of	 the	episode.	 Focal	
seizures	were	considered	with	other	episodes,	as	motor	manifestations	 can	widely	vary	 in	
those	seizures,	but	are	most	commonly	less	marked	than	in	GTC	seizures.	Focal	seizure	tended	
to	be	associated	with	 lower	proportion	of	abnormal	phosphatemia,	but	the	 limited	sample	
size	precludes	any	conclusion.	
	
A	 basic	 limitation	 of	 all	 studies	 relying	 on	 a	 diagnosis	 of	 seizure	 is	 the	 absence	 of	 a	 gold	
standard	diagnostic	procedure;	the	diagnosis	is	therefore	based	heavily	on	history	taking.	This	
limitation	highlights	that	biological	potential	biomarkers	should	be	interpreted	together	with	
the	episode	description	as	these	markers	were	established	in	the	first	place	based	on	clinical	
data	(mostly	history).	The	usefulness	of	these	markers	(phosphate	level	possibly	among	them)	
could	be	situations	where	no	description	of	the	LOC	is	available.		
In	conclusion,	hypophosphatemia	is	commonly	(51%)	found	following	GTC	seizures,	this	more	
often	 than	 following	 others	 LOC	 such	 as	 syncopes.	 	 Hypophosphatemia	 below	 0.6mmol/l	
seems	reasonably	sensitive	and	specific	to	suggest	a	GTC	seizures	and	it	could	be	therefore	
used	a	diagnostic	help	especially	when	history	is	not	available.	A	prospective	study	is	needed	
to	confirm	these	findings,	together	with	other	established	markers	of	seizures.	
	
	 	 	
	
	
Figure	1	 legend:	Distribution	of	plasma	electrolytes	 for	sodium,	potassium,	phosphate,	calcium	and	
magnesium	(mmol/l)	in	GTC	seizure	and	in	other	LOC	episodes.	Phosphate	and	total	calcium	showed	
both	a	significant	distribution	between	GTC	seizures	and	other	LOC;	median	0.79,	range	0.34-1.37	in	
GTC	seizure	vs	median=0.94,	range	0.52-1.89	 in	other	LOC	for	phosphate	(p=0.007,	Mann-Whitney)	
and	median=2.32,	range	1.92-2.53	vs	median=2.27,	range	2-2.53	(p=0.03,	Mann-Whitney)	for	calcium.	
Both	decreased	phosphatemia	(OR:	0.04,	95%	CI:	0.29-0.007,	p=0.001)	and	increase	calcemia	(OR:57,	
95%	CI:	1.3-2432,	p=0.03)	were	independently	associated	with	GTC	seizures.	Na,	K,	and	Mg	showed	no	
different	distribution	for	GTC	seizure.		
	
	 All		
n=	128	
GTC	 seizures	
n=	75	
Others	LOC		
n=	46	
Test	 p	
Age	 Median:	48	
Range:	[18-90]	
Median:	43	
Range:	[18-86]	
Median:	50	
Range:	[19-90]	
Mann-
Withney	
0.52	
Genre	(F)	 51	(40%)	 29	(39%)	 21	(46%)	 Chi2	 0.45	
History	 of	
alcohol	abuse	
10	(8%)	 8	(11%)	 0		 Fisher’s	exact	 0.03	
Delay	 of	 the	
blood	sample	
Median:	2	h	
Range:	6	min-20h	
Median:	1.7h	
Range:	6	min-17h	
Median:	2h	
Range:	0.5h–20h	
Mann-
Withney	
0.003	
Abnormal	Na	 16	(13%)	 8	(11%)	 8	(17%)	 Chi2	 0.43	
Abnormal	K	 19	(15%)	 10	(14%)	 9	(20%)	 Chi2	 0.98	
Abnormal	PO4	 52	(41%)	 37	(51%)	 15	(33%)		 Chi2	 0.02	
Abnormal	Ca	 12	(9%)	 5	(7%)	 16	(35%)	 Fisher’s	exact	 0.11	
Abnormal	Mg	 5	(4%)	 4	(6%)	 1	(2%)	 Fisher’s	exact	 0.65	
	
	 	 	
	
Table	1	legend	
Demographic	characteristics	and	abnormal	electrolytic	plasma	levels	in	whole	series,	in	GTC	
seizures	and	others	LOC.	Significant	p	values	are	in	bold.	
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